Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer. [electronic resource] by
- Vincent, M D
- Breadner, D
- Cripps, M C
- Jonker, D J
- Klimo, P
- Biagi, J J
- Lam, W
- O'Connell, A
- Whiston, F
- Stitt, L
- Welch, S A
Publication details: Current oncology (Toronto, Ont.) Aug 2017
In:
Current oncology (Toronto, Ont.) vol. 24
Availability: No items available.
|
|
|
8.
|
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. [electronic resource] by
- Morgen, E K
- Lenz, H-J
- Jonker, D J
- Tu, D
- Milano, G
- Graziano, F
- Zalcberg, J
- Karapetis, C S
- Dobrovic, A
- O'Callaghan, C J
- Liu, G
Producer: 20180718
In:
The pharmacogenomics journal vol. 17
Availability: No items available.
|
|
|
9.
|
Tissue Factor Pathway Inhibitor Gene Polymorphism -33T → C Predicts Improved Disease-Free Survival in Colorectal Cancer. [electronic resource] by
- Bazzarelli, A K
- Scheer, A S
- Tai, L H
- Seth, R
- de Souza, C Tanese
- Petrcich, W
- Jonker, D J
- Maroun, J A
- Carrier, M
- Auer, R C
Producer: 20180223
In:
Annals of surgical oncology vol. 23
Availability: No items available.
|
|
|
10.
|
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3. [electronic resource] by
- Vickers, M M
- Lee, C
- Tu, D
- Wheatley-Price, P
- Parulekar, W
- Brundage, M D
- Moore, M J
- Au, H
- O'Callaghan, C J
- Jonker, D J
- Ringash, J
- Goldstein, D
Producer: 20170404
In:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] vol. 16
Availability: No items available.
|
|
|
11.
|
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care. [electronic resource] by
- Asmis, T R
- Powell, E
- Karapetis, C S
- Jonker, D J
- Tu, D
- Jeffery, M
- Pavlakis, N
- Gibbs, P
- Zhu, L
- Dueck, D-A
- Whittom, R
- Langer, C
- O'Callaghan, C J
Producer: 20110322
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
12.
|
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. [electronic resource] by
- Brulé, S Y
- Jonker, D J
- Karapetis, C S
- O'Callaghan, C J
- Moore, M J
- Wong, R
- Tebbutt, N C
- Underhill, Cr
- Yip, D
- Zalcberg, J R
- Tu, D
- Goodwin, R A
Producer: 20150909
In:
European journal of cancer (Oxford, England : 1990) vol. 51
Availability: No items available.
|
|
|
13.
|
A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer. [electronic resource] by
- Chow, L Q M
- Blais, N
- Jonker, D J
- Laurie, S A
- Diab, S G
- Canil, C
- McWilliam, M
- Thall, A
- Ruiz-Garcia, A
- Zhang, K
- Tye, L
- Chao, R C
- Camidge, D R
Producer: 20120420
In:
Cancer chemotherapy and pharmacology vol. 69
Availability: No items available.
|
|
|
14.
|
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors. [electronic resource] by
- Peethambaram, P P
- Hartmann, L C
- Jonker, D J
- de Jonge, M
- Plummer, E R
- Martin, L
- Konner, J
- Marshall, J
- Goss, G D
- Teslenko, V
- Clemens, P L
- Cohen, L J
- Ahlers, C M
- Alland, L
Producer: 20160119
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
|
15.
|
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors. [electronic resource] by
- Jonker, D J
- Rosen, L S
- Sawyer, M B
- de Braud, F
- Wilding, G
- Sweeney, C J
- Jayson, G C
- McArthur, G A
- Rustin, G
- Goss, G
- Kantor, J
- Velasquez, L
- Syed, S
- Mokliatchouk, O
- Feltquate, D M
- Kollia, G
- Nuyten, D S A
- Galbraith, S
Producer: 20111128
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
16.
|
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. [electronic resource] by
- Jonker, D J
- Karapetis, C S
- Harbison, C
- O'Callaghan, C J
- Tu, D
- Simes, R J
- Malone, D P
- Langer, C
- Tebbutt, N
- Price, T J
- Shapiro, J
- Siu, L L
- Wong, R P W
- Bjarnason, G
- Moore, M J
- Zalcberg, J R
- Khambata-Ford, S
Producer: 20140407
In:
British journal of cancer vol. 110
Availability: No items available.
|
|
|
17.
|
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial. [electronic resource] by
- Horgan, A M
- Darling, G
- Wong, R
- Guindi, M
- Liu, G
- Jonker, D J
- Lister, J
- Xu, W
- MacKay, H M
- Dinniwell, R
- Kim, J
- Pierre, A
- Shargall, Y
- Asmis, T R
- Agboola, O
- Seely, A J
- Ringash, J
- Wells, J
- Marginean, E C
- Haider, M
- Knox, J J
Producer: 20170425
In:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus vol. 29
Availability: No items available.
|
|
|
18.
|
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17. [electronic resource] by
- Vickers, M M
- Karapetis, C S
- Tu, D
- O'Callaghan, C J
- Price, T J
- Tebbutt, N C
- Van Hazel, G
- Shapiro, J D
- Pavlakis, N
- Gibbs, P
- Blondal, J
- Lee, U
- Meharchand, J M
- Burkes, R L
- Rubin, S H
- Simes, J
- Zalcberg, J R
- Moore, M J
- Zhu, L
- Jonker, D J
Producer: 20130904
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|